LONDON (Reuters) - Britain on Wednesday said it had approved the Pfizer-BioNTech vaccine for use and that it will be rolled out for use from next week.
“The Government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s COVID-19 vaccine for use,” the government said.
“The vaccine will be made available across the UK from next week.”
Asian shares rose on Wednesday after a strong lead from Wall Street fuelled by hopes for additional U.S. economic stimulus and a coronavirus vaccine.
The U.S. Transportation Department said Tuesday it has made preparations to enable the “immediate mass shipment” of COVID-19 vaccines and completed all necessary regulatory measures.
The department said U.S. agencies have been coordinating with private sector companies that will carry vaccines from manufacturing facilities to distribution centers and inoculation points.
It added it has established “appropriate safety requirements for all potential hazards involved in shipping the vaccine, including standards for dry ice and lithium batteries used in cooling.”
The department is preparing to ensure deliveries of vaccine doses for about 40 million U.S. residents through January, or about 20 million a month, officials told Reuters.
How will markets react today?